drugset / Trial / NCT02882269

Neoadjuvant Chemotherapy for the Treatment of Resectable Locally Advanced Colon Cancer

NCT02882269

RandomizedParallel-groupOpen-labelTreatment

Summary

A randomized controlled clinical trial to compare the short and long outcomes of Neoadjuvant chemotherapy with postoperative chemotherapy in patients with resectable locally advanced colon cancer

Timeline

Start
2016-12
Primary completion
2021-12
Completion
2021-12

Drugs

EvaluationDrugModalityDoseRoute
Comparator Capecitabine Small molecule

Indications